视眼瘤中室内药物输送系统的概述
Kelvin S Y Shi1, Yazan Abubaker1, Mary V Lang1,2
1Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA.
Clinical ophthalmology (Auckland, N.Z.)
|February 26, 2026
概括
新的室内药物输送系统 (DDS) 为玻璃眼患者提供持续的眼内压力 (IOP) 控制,减少药物负担. 然而,为了最佳的临床使用,仍需要长期安全性和比较疗效数据.
科学领域:
- 眼科医生 眼科 眼科
- 药物输送系统 药物输送系统
- 玻璃眼研究研究 玻璃眼研究
背景情况:
- 玻璃眼是全球不可逆转失明的主要原因.
- 升高的眼内压力 (IOP) 是主要可改变的风险因素.
- 局部药物虽然是标准药物,但其粘附性和生物可用性较差.
研究的目的:
- 审查玻璃眼内腔药物输送系统 (DDS) 的设计和临床性能.
- 讨论FDA批准的和正在研究的室内植入物.
- 为临床医生强调关于这些新疗法的关键考虑因素.
主要方法:
- 对已批准和正在研究的室内DDS进行临床试验数据的审查.
- 实践研究对持续的IOP降低进行分析.
- 评估安全问题,包括角膜内皮细胞损失 (CECL).
主要成果:
- 室内DDS显示持续的IOP降低,相当于局部前列腺素 (PGA).
- 现实世界的数据显示,IOP和药物负担降低了.
- 局限性包括潜在的CECL,晚期疾病的可变反应,以及有限的长期数据.
结论:
- 室内DDS显示出在玻璃眼治疗中持续控制IOP的前景.
- 需要进一步研究长期的安全性,耐用性和对MIGS的比较有效性.
- 这些设备代表了个性化的青光眼治疗策略的发展领域.
相关概念视频
Ophthalmic Drug Delivery Systems
97
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
97
Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Drug Delivery: Miscellaneous Routes
885
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
885
Intrauterine Drug Delivery Systems
57
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
57


